Semaglutide has emerged as a novel treatment for type 2 diabetes. This synthetic glucagon-like peptide-1 (GLP-1) receptor agonist acts upon stimulating the pancreas to produce more insulin and reducing glucagon https://blakevbdd122944.kylieblog.com/36269882/grasping-semaglutide-a-comprehensive-guide